News and commentary from the psychiatry world ...

The FDA just got sued by major health groups over a policy letting vapes and nicotine pouches stay on shelves without real ...

Would you want two strangers in the room with you for hours while you're on mushrooms? The federal government just decided ...

A coalition of public health organizations, pediatricians and parents file a lawsuit in the U.S. District Court for the ...

The drug from Merck was OK'd for patients with artery-clogging cholesterol that persists even after taking statins.

Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path directly into a pivotal Phase 3 studyWith the vast majority of PMD patients having no ...

Taylor Farms de Mexico lettuce sample tested positive for cyclospora, FDA said, as officials investigate a multistate ...

The FDA is holding a public hearing to talk through psychedelic drug development on 14 September.

FDA finalized new guidance for testing MDMA and psilocybin in trials, days after Massachusetts advanced its own psychedelic ...

Merck’s pill, called Lipfendra, is a PCSK9 inhibitor, which works in a different way from a statin to lower cholesterol.

The U.S. Sentencing Guidelines play a pivotal role in some of the federal government's most consequential drug policy ...

The FDA approved Lipfendra, a new drug for adults with high LDL cholesterol, as the first PCSK9 inhibitor available as a once ...